3. Segment Information and Concentrations

6 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (“Benchtop Laboratory Equipment”), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (“Catalyst Research Instruments”) and the marketing and production of bioprocessing systems for laboratory research in the biotechnology industry sold directly to customers and through distributors (“Bioprocessing Systems”).

  Segment information is reported as follows (foreign sales are principally to customers in Europe and Asia):

	Benchtop Laboratory Equipment		Catalyst Research Instruments		Bioprocessing Systems			Corporate and Other		Consolidated
Three months ended December 31, 2016:
Revenues	$	1,466,800	$	1,192,100	$	24,900		$	—	$	2,683,800
Foreign Sales		751,800		10,300		—			—		762,100
Income (Loss) from Operations		62,600		26,600		(32,700	)		—		56,500
Assets		4,131,400		1,982,800		434,700			695,900		7,244,800
Long-Lived Asset Expenditures		5,200		—		5,800			—		11,000
Depreciation and Amortization		76,700		4,500		12,600			—		93,800

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2015:
Revenues	$	1,583,500	$	414,500		$	30,200		$	—		$	2,028,200
Foreign Sales		764,400		105,500			—			—			869,900
Income (Loss) from Operations		187,700		(10,100	)		(32,900	)		(14,000	)		130,700
Assets		4,352,600		2,319,200			728,800			578,300			7,978,900
Long-Lived Asset Expenditures		1,900		—			5,700			—			7,600
Depreciation and Amortization		74,200		7,000			24,400			—			105,600

Approximately 55% and 53% of net sales of benchtop laboratory equipment (30% and 41% of total revenues) for the three month periods ended December 31,2016 and 2015, respectively, were derived from the Company’s main product, the Vortex-Genie 2® mixer, excluding accessories.

Approximately 21% and 19% of net sales of benchtop laboratory equipment (15% and 11% of total net revenues) were derived from Torbal brand products for the three months ended December 31, 2016 and 2015, respectively.

Two customers accounted in the aggregate for approximately 17% and 14% of the net sales of the Benchtop Laboratory Equipment Operations (9% and 11% of total net revenues) for the three months ended December 31, 2016 and 2015, respectively. Sales of catalyst research instruments generally comprise a few very large orders averaging at least $100,000 per order to a limited number of customers, who differ from order to order. Sales to three and two customers (one of which is the same) represented approximately 99% and 92% of the Catalyst Research Instrument Operations’ net sales, respectively, and 44% and 19% of total revenues for the three months ended December 31, 2016 and 2015, respectively.

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other		Consolidated
Six months ended December 31, 2016:
Revenues	$	2,923,600	$	1,269,600		$	49,700		$	—	$	4,242,900
Foreign Sales		1,313,000		15,100			—			—		1,328,100
Income (Loss) from Operations		164,000		(115,000	)		(67,400	)		—		(18,400	)
Assets		4,131,400		1,982,800			434,700			695,900		7,244,800
Long-Lived Asset Expenditures		13,600		—			5,800			—		19,400
Depreciation and Amortization		153,400		11,100			25,000			—		189,500

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2015:
Revenues	$	2,846,500	$	567,500		$	58,600		$	—		$	3,472,600
Foreign Sales		1,363,400		113,300			—			—			1,476,700
Income (Loss) from Operations		242,400		(92,200	)		(62,900	)		(22,100	)		65,200
Assets		4,352,600		2,319,200			728,800			578,300			7,978,900
Long-Lived Asset Expenditures		8,400		—			5,700			—			14,100
Depreciation and Amortization		148,000		13,900			48,900			—			210,800

Approximately 52% and 50% of net sales of benchtop laboratory equipment (36% and 41% of total revenues) for the six month periods ended December 31, 2016 and 2015, respectively, were derived from the segment’s main product, the Vortex-Genie 2® mixer, excluding accessories.

Two benchtop laboratory equipment customers, accounted in the aggregate for approximately 16% and 13% of the segment’s net sales for the six month periods ended December 31, 2016 and 2015, and 11% of total revenues for both periods.

Approximately 23% and 20% of net sales of benchtop laboratory equipment (16% of total revenues for both periods) were derived from Torbal brand products for the six months ended December 31, 2016 and 2015, respectively.

For the six month periods ended December 31, 2016 and 2015, catalyst research each of the six month periods, accounted for approximately 97% and 88% of the segment’s net sales and 29% and 14% of total revenues, respectively.